Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Wellington Partners

Investor type Venture Capital
Founders Rolf Christof Dienst


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 227
Average round size
The average size of a deal this fund participated in
Portfolio companies 125
Rounds per year 9.46
Lead investments 54
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 50
Key employees 7
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Software
  • Therapeutics

Wellington Partners appeared to be the VC, which was created in 1998. The fund was located in Europe if to be more exact in Germany. The main department of described VC is located in the Munich.

The fund was created by Rolf Christof Dienst. Besides them, we counted 7 critical employees of this fund in our database.

The important activity for fund was in 2014. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 11 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2014. The fund is constantly included in 7-12 investment rounds annually. The average startup value when the investment from Wellington Partners is more than 1 billion dollars. Opposing the other organizations, this Wellington Partners works on 7 percentage points less the average amount of lead investments.

Among the most successful fund investment fields, there are Therapeutics, E-Commerce. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Spotify, Carisma Therapeutics, Livebookings Holdings Ltd.. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Germany. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Wellington Partners, startups are often financed by Auriga Partners, 3i Group, High-Tech Gru00fcnderfonds. The meaningful sponsors for the fund in investment in the same round are Balderton Capital, Partech, Cipio Partners. In the next rounds fund is usually obtained by Balderton Capital, OpenOcean, Northzone.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Wellington Partners:
Typical Co-investors
Wellington Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Wellington Partners:

Funds with similar focus

Funds from Germany
Funds with similar focus located in Germany:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Orcan Energy

$33M27 Sep 2022 Munich, Bavaria, Germany

Carisma Therapeutics

Health Care
Life Science
$30M21 Sep 2022 Philadelphia, Pennsylvania, United States


Health Care
Medical Device
$55M16 Sep 2022 Paris, Ile-de-France, France


Artificial Intelligence
Health Care
Health Diagnostics
Machine Learning
$16M15 Sep 2022 Berlin, Berlin, Germany

ImCheck Therapeutics

Health Care
Life Science
$113M13 Jun 2022 Marseille, Provence-Alpes-Côte d'Azur, France

Cayaba Care

Health Care
$12M19 May 2022 Philadelphia, Pennsylvania, United States


Health Care
Health Diagnostics
$55M05 May 2022 Gothenburg, Västra Götaland County, Sweden


Financial Services
$111M02 May 2022 Las Condes, Santiago Metropolitan Region, Chile


$22M09 Dec 2021 Austin, Texas, United States
eGenesis Raises $125M in Series C Financing

– eGenesis from Cambridge, Mass. develops human-compatible organs, tissues, and cells.
– The company raised $125m in Series C funding.
– Backers included Farallon Capital Management, Polaris Partners, HBM Healthcare Investments, Invus, Samsara BioCapital, LifeSci Venture Partners, Irving Investors, Catalio Capital Management, SymBiosis, Altium Capital, Monashee Investment Management, and Osage University Partners and existing investors Leaps by Bayer, Fresenius Medical Care Ventures, ARCH Venture Partners, Wellington Partners, Khosla Ventures, and Alta Partners.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Wellington Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: